News
CLL can mean fatigue, fear and years of waiting but new research shows that staying active helps people feel better – and ...
Ryan Dolce is crisscrossing the country on a quest to donate platelets at every Red Cross site in America. So far, he's hit ...
EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a comeback.
The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing ...
Researchers from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg and ETH Zurich have created the first integrated map detailing the metabolic and molecular changes in human blood ...
To solve the mystery of the Guadeloupian woman’s incompatible blood, scientists turned to cutting-edge genetic analysis.
(NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today ...
A 68-year-old man with 1 week of bloating and constipation undergoes CT, which reveals Stanford type B aortic dissection ...
6d
Tribune Content Agency on MSNAsk the Doctors: New Immunotherapy Drug Could Slow Type 1 DiabetesType 1 diabetes runs in our family. Because of that, our pediatrician asked to do blood tests with our son to check if Type 1 is beginning. She also said that if it shows up, there’ s a medicine that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results